Other studies have indicated that BCR-ABL1 translocation (Philadelphia chromosome,Ph) in chronic myelocytic leukemia (CML) may modulate DIDO1 expression in a JAK2V617F-independent manner [9] [10]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.